https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png
0
0
Max
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png
Max2025-04-28 20:27:142025-04-28 20:27:14UPDATE: ATNM-400 a Promising Antibody Radioconjugate Delivering 225 Ac
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png
0
0
Max
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png
Max2025-04-28 10:53:332025-04-28 10:53:33OST11098: A Promising New Approach for Castration-Resistant Prostate Cancer
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png
0
0
Max
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png
Max2025-04-28 10:40:362025-04-28 10:40:36Phase 1 Trial: APG-5918 an EED Inhibitor for Prostate Cancer Therapy
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png
0
0
Max
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png
Max2025-04-28 10:07:502025-04-28 10:07:50SHR3591 Shows Promise in Tackling Resistant Prostate Cancer
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png
0
0
Max
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png
Max2025-04-28 09:06:202025-04-28 09:06:20Phase 1 Trial: CTS2190 Targets Advanced Prostate Cancer
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png
0
0
Max
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png
Max2025-04-28 08:44:122025-04-28 08:44:12Phase 1 trial: SYN818 Shows Promise for Prostate Cancer Patients With HRR Genetic Mutations
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png
0
0
Max
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png
Max2025-04-28 08:28:102025-04-28 08:28:10Phase 1 Trial: NXP900 for Overcoming Resistance in Advanced Prostate Cancer
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png
0
0
Max
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png
Max2025-04-28 07:04:292025-04-27 18:10:00Phase 1 Recruiting: ABBV-969, A Novel Bispecific Antibody Drug Conjugate for Advanced Prostate Cancer